PM Images bluebird bio ( NASDAQ: BLUE ) said it is seeking to expand its cash runway as its current cash and cash equivalents are only suitable to fund operations through Q1 2025. The biotech noted that it believes it can achieve quarterly cash flow.
Back to Health Page
